Funded Projects

Top Funded Faculty

Based on current funded research

Current Funded Research

Updated February 3, 2023
Data provided by University at Buffalo Sponsored Projects Services

Current Funded Research
Award Principal Investigator Award Name Award Type Sponsor Name Award Start Date Award End Date Total Cost
Balthasar, Dr. Joseph Center for Protein Therapeutics Nonfederal Multiple Sponsors 1-Sep-17 31-Aug-23 9,374,503.70
Balthasar, Dr. Joseph Pharmacokinetic strategies to increase monoclonal antibody uptake, distribution, and efficacy for treatment of solid tumors Federal National Cancer Institute 1-Jun-20 31-May-25 1,807,227.00
Balthasar, Dr. Joseph Enhancement of ADC selectivity by inverse targeting: Mechanistic studies and optimization Federal National Cancer Institute 1-Jun-21 31-May-26 1,817,098.00
Balthasar, Dr. Joseph
SBIR A1: Lead Optimization and Evaluation of Anti-SN38 Payload Binding Selectivity Enhancers
Federal Abceutics 15-Sep-21 31-Aug-23 55,000.00
Balu-Iyer, Dr. Sathy V.
Lipid mediated oral tolerance
Federal National Institute of Allergy & Infectious Disease 16-Jun-22 31-May-27 2,327,530.00
Bednarczyk, Dr. Edward M.
C19: Chronic Disease Medication Utilization and the Novel Coronavirus Disease 2019 (COVID-19) Infection
Nonfederal American College of Clinical Pharmacy 01-Jan-21 31-Jul-23 600.00
Bednarczyk, Dr. Edward M. NYS Prescription Monitoring CE Program Federal Flow Through Island Peer Review Organization 1-Sep-21 31-Dec-23 188,394.00
Bednarczyk, Dr. Edward M.
Opioid Prescriber Training Program
Federal Flow Through Health Research Inc. 1-Sep-2022 31-Aug-2023 70,000
Bies, Dr. Robert R. Physiologically-based model of the female reproductive tract: vaginal and intrauterine delivery components- Support New Approaches to Improve Product Manufacturing and Quality Federal US Food and Drug Administration 26-Sep-18 25-Jan-24 940,749.00
Bies, Dr. Robert R. Pharmacokinetics of sedatives - Understanding a modifiable risk factor for pediatric delirium Federal Flow Through Childrens Research Institute 1-Sep-19 31-Jul-24 77,492.00
Bies, Dr. Robert R.
Long Acting Film Technology for Contraception and HIV Prevention (LATCH)
Federal Flow Through
Magee-Womens Research Institute and Foundation
1-Feb-21 31-Jan-23 174,200.00
Bies, Dr. Robert R.
Evaluation of safety and pharmacokinetics of naltrexone implant
Federal Flow Through
Research Foundation for Mental Hygiene
1-Mar-21 31-Aug-23 180,584.00
Bies, Dr. Robert R. The Indiana University-Ohio State University Maternal and Pediatric Precision in Therapeutics Data, Model, Knowledge, and Research Coordination Center (IU-OSU MPRINT DMKRCC) Federal Flow Through Trustees of Indiana University 10-Sep-2021 31-Jul-26 1,913,969.00
Bies, Dr. Robert R. Microbicide R&D to Advance HIV Prevention Technologies through Responsive Innovation and eXcellence, MATRIX Federal Flow Through Magee-Womens Research Institute and Foundation 01-Dec-2021 31-Dec-26 993,854.00
Bies, Dr. Robert R
Population Pharmacokinetic Modeling and Clinical Trial Simulation to optimize HIV Prevention in Pregnancy and Postpartum
Federal Flow Through Medstar Health Research Institute 01-Aug-22 31-Mar-23 78,021.00
Cha, Dr. Raymond FELLOWSHIP for Melissa Stein (AFPE Gateway to Research)
Nonfederal American Foundation Pharmaceutical Education 01-Jul-22 30-Jun-23 5,000.00
Clark, Dr. Collin M. A Pilot Pharmacist-to-Pharmacist Hand-off Intervention During Transitions of Care
Nonfederal American Association of Colleges of Pharmacy
01-Mar-23 28-Feb-24 7,500.00
Daly, Dr. Christopher Effectiveness of a Social Determinants of Health Pharmacy Program Implemented in Community Pharmacies
Federal Flow Through Island Peer Review Organization 01-Aug-22 07-Nov-24 68,254.00
Jacobs, Dr. David Matthew Integrative Informatics Approach to Predict Readmissions and Improve Outcomes in COPD Federal National Heart Lung and Blood Institute 1-Apr-21 31-Mar-26 962,055.00
Jusko, Dr. William J. Mechanistic Pharmacokinetics and Pharmacodynamics Federal National Institute of General Medical Sciences 1-May-19 30-Apr-24 2,891,677.00
Jusko, Dr. William J. Training Program in Pharmacokinetics and Pharmacodynamics Nonfederal GlaxoSmithKline 3-Feb-21 30-Sep-23 255,200.00
Ma, Dr. Qing
Doravirine Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals
Nonfederal Merck Sharp and Dohme Limited Liability Corporation 04-Jun-19 30-Jun-23 167,705.69
Ma, Dr. Qing Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV Federal National Institute on Aging 1-May-20 28-Feb-25 4,006,139.00
Ma, Dr. Qing Bictegravir in the Elderly Living with HIV: Impact of Polypharmacy and Multimorbidity Nonfederal Gilead Sciences Incorporated 1-Oct-19 30-Sep-23 155,175.00
Mager, Dr. Donald E. Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments Federal Flow Through Childrens Hospital of Boston 1-Sep-18 30-Jun-23 655,057.00
Mager, Dr. Donald E. Optimizing GVHD Prevention with Systems Pharmacology Models Federal Flow Through Beckman Research Institute of the City of Hope 1-Jun-19 31-May-24 543,822.00
Mager, Dr. Donald E.
Genetic and Epigenetic Vulnerabilities in Prostate Cancer of African American Men
Federal Flow Through Health Research Inc. 1-Aug-21 31-Jul-23 112,653.00
Morse, Dr. Gene Global Infectious Diseases Research Training Program Federal Fogarty International Center 11-Apr-18 28-Feb-23 1,125,653.00
Morse, Dr. Gene
ACTG Precautionary and Prohibited Medications Database
Federal Flow Through
Regents of the University of California Los Angeles
1-Dec-20 31-May-23 475,000.00
Morse, Dr. Gene University of Rochester HIV/AIDS Clinical Trial Unit - AWD00003932
Federal Flow Through University of Rochester 01-Dec-2020 30-Nov-27 108,295.00
Morse, Dr. Gene C19: NYU: CBD, Morphine, Hydrocodone, and Oxycodone levels in human plasma samples Nonfederal New York University 01-Dec-2021 30-Apr-23 38,000.00
Morse, Dr. Gene
HIV Clinical Pharmacology & Therapeutics Research Training Program
Federal Fogarty International Center 1-Mar-22 31-Jan-27 1,580,866.94
Morse, Dr. Gene
Clinical Pharmacology Quality Assurance (CPQA)
Federal National Institute of Allergy & Infectious Disease
30-May-22 29-May-29 13,062,971.00
Morse, Dr. Gene
LC-MS/MS Assay Development and Validation for CBD and CBD hydroxy metabolite
Nonfederal Ananda Scientific 26-Apr-22 25-Jul-23 62,441.00
Morse, Dr. Gene
CENTER FOR INTEGRATED GLOBAL BIOMEDICAL SCIENCES
Nonfederal Abbott Laboratories
23-Nov-22 31-Aug-23 174,900.00
Qu, Dr. Jun
The Network Biology of Pathogen-Host Interactions Driving Exacerbation in Chronic Obstructive Pulmonary Disease (COPD)
Federal Buffalo Institute for Medical Research 15-Sep-19 14-Sep-23 335,351.00
Qu, Dr. Jun Highly sensitive multiplexed targeted mass spectrometric assays of proteins/peptides of significance in obesity research Federal Flow Through Pacific Northwest National Laboratory 19-Feb-20 31-Jul-23 618,520.00
Qu, Dr. Jun Extracellular Vesicle treatment and age-related neuropathology in non-human primates Federal Flow Through Trustees of Boston University 15-Sep-20 30-Apr-25 214,632.00
Qu, Dr. Jun
Role of Type 2 Immune Response in Pancreatic Cancer Tumorgenisis
Federal Flow Through Health Research Inc. 15-Jul-21 30-Jun-23 19,687.00
Qu, Dr. Jun GMPS-GMPR axis melanoma progression and therapy Federal Flow Through Duke University 01-Aug-22 31-Jul-23 23,352.00
Qu, Dr. Jun
Dissecting the Mechanism of SETDB1 and its K867 Monoubiquitination in Lung Cancer Progression
Federal Flow Through Health Research Inc. 05-Aug-22 31-Jul-23 7,368.00
Qu, Dr. Jun
Neuroinflammation-related phosphoprotein signaling pathways as potential therapeutic targets for GWI using an established animal model
Federal Flow Through Virginia Commonwealth University
1-Feb-23 30-Apr-23 9,474.00
Qu, Dr. Jun
Mitochondrial Defects in the Retinal Pigment Epithelium and the CFH Risk Allele for Age-related Macular Degeneration
Federal Flow Through Doheny Eye Institute
30-Sep-22 30-Jun-26 257,000.00
Qu, Dr. Jun
Deciphering the Mechanisms Associated with High-risk AMD genotypes for ARMS2/HTRA1 and Complement Factor H
Federal Flow Through Doheny Eye Institute
30-Sep-22 31-Aug-25 191,400.00
Ramanathan, Dr. Murali The Metabolomics-Neurofilaments-Neurodegeneration Nexus in Multiple Sclerosis Progression Federal US Army Medical Research Acquisition Activity 1-Jul-20 30-Jun-23 957,000.00
Shah, Dr. Dhavalkumar
Development of organ-specific quantitative systems toxicology models for antibody-drug conjugates
Nonfederal AstraZeneca Pharmaceuticals LP
1-Apr-22 09-Oct-25 465,771.00
Sprowl, Dr. Jason Arthur Regulation of hepatic uptake transporters by tyrosine kinases Federal National Institute of General Medical Sciences 15-Sep-2021 31-Aug-26 2,321,588.00
Straubinger, Dr. Robert M. Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development
Federal National Cancer Institute 21-Dec-18 31-May-23 398,683.00
Tornatore, Dr. Kathleen M. Age and Race Influences on Immunosuppression after Renal Transplant Federal National Institute on Aging 15-Aug-18 30-Jun-23 3,507,814.00
Tsuji, Dr. Brian T. Novel Strategies for Antibiotic Combinations to Combat Gram-negative Superbugs Federal National Institute of Allergy & Infectious Disease 20-Dec-19 30-Nov-24 3,920,362.00
Tsuji, Dr. Brian T.
Exploitation of multiple heteroresistance for effective antibiotic combination therapy
Federal Flow Through Emory University 1-Jul-20 30-Jun-23 304,248.00
Tsuji, Dr. Brian T.
Novel Combination Therapies to Combat Hypermutable Carbapenem-Resistant P. aeruginosa
Federal National Institute of Allergy & Infectious Disease 24-May-22 30-Apr-27 3,850,992.00
Woo, Dr. Sukyung Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition Federal National Cancer Institute 01-Dec-2021 30-Nov-26 1,978,058.00
Woo, Dr. Sukyung
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
Federal Flow Through Board of Regents of the University of Oklahoma 01-Jul-22 30-Jun-27 449,744.00
You, Dr. Young Jae
Singlet Oxygen-cleavable Prodrugs for Treating Non-Muscle Invasive Bladder Cancers
Federal National Cancer Institute 13-Jul-22 30-Jun-27 2,105,595.00